Shai Novik
Fortune : 51 725 $ au 31/10/2026
Fortune : 51 725 $ au 31/10/2026
Mr. Shai A. Novik is an Executive Chairman at Enlivex Ltd. and a Chairman at Stentomics, Inc. He is on the Board of Directors at InnoVision Labs, Inc. and Odysseus Ventures Ltd. Mr. Novik was previously employed as a Chairman by Enlivex Therapeutics Ltd. /Old/, a Chairman by Autovative Products, Inc., a Chairman by InnoVision Labs, Inc., a President by OPKO Biologics Ltd., a Managing Director by A-Online Capital (A.O.C.) Ltd., a Chief Operating Officer & Head-Strategic Planning by THCG, Inc., a Chief Operating Officer by Invmetrics Holdings, Inc., and a Chairman by Sharp Vision, Inc. He also served on the board at Cazador Acquisition Corp.
Ltd. and Ucansi, Inc. He received his MBA from Cornell University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ENLIVEX LTD. 1,9% | 18/03/2026 | 29 059 ( 1,9% ) | 51 725 $ | 31/10/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ENLIVEX LTD. | Président | 01/01/2014 |
| INNOVISION LABS, INC. | Directeur/Membre du Conseil | 01/01/2013 |
Stentomics, Inc. | Fondateur | 06/09/2010 |
Odysseus Ventures Ltd. | Directeur/Membre du Conseil | 06/09/2010 |
| Sociétés | Poste | Fin |
|---|---|---|
OPKO Biologics Ltd.
OPKO Biologics Ltd. BiotechnologyHealth Technology Operates as a drug development company that develops bio-better long-acting therapeutic proteins | Fondateur | 01/01/2014 |
Autovative Products, Inc.
Autovative Products, Inc. Wholesale DistributorsDistribution Services Produces and distributes automotive parts | Président | 12/08/2013 |
Ucansi, Inc.
Ucansi, Inc. Packaged SoftwareTechnology Services Develops solutions for treating presbyopia | Directeur/Membre du Conseil | 12/08/2013 |
Cazador Acquisition Corp. Ltd.
Cazador Acquisition Corp. Ltd. Financial ConglomeratesFinance Operates as a blank check company | Directeur/Membre du Conseil | 04/10/2012 |
| A-ONLINE CAPITAL (A.O.C) LTD. | President | 01/01/2002 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 13 |
|---|---|
THCG, Inc.
THCG, Inc. Finance/Rental/LeasingFinance Provides venture funding, venture development, and venture banking services | Finance |
A-Online Capital (A.O.C.) Ltd.
A-Online Capital (A.O.C.) Ltd. Packaged SoftwareTechnology Services Develops trading and investment portfolio analysis software solutions | Technology Services |
OPKO Biologics Ltd.
OPKO Biologics Ltd. BiotechnologyHealth Technology Operates as a drug development company that develops bio-better long-acting therapeutic proteins | Health Technology |
Autovative Products, Inc.
Autovative Products, Inc. Wholesale DistributorsDistribution Services Produces and distributes automotive parts | Distribution Services |
Cazador Acquisition Corp. Ltd.
Cazador Acquisition Corp. Ltd. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rogerscasey, Inc.
Rogerscasey, Inc. Investment ManagersFinance Provides investment consulting services | Finance |
Enlivex Therapeutics Ltd. /Old/
Enlivex Therapeutics Ltd. /Old/ Medical SpecialtiesHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Health Technology |
Stentomics, Inc. | |
Ucansi, Inc.
Ucansi, Inc. Packaged SoftwareTechnology Services Develops solutions for treating presbyopia | Technology Services |
Odysseus Ventures Ltd. | |
InnoVision Labs, Inc.
InnoVision Labs, Inc. Packaged SoftwareTechnology Services Operates as visual neuroscience software technology company | Technology Services |
Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd. BiotechnologyHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national